Key facts
- It has raised $52.0M; the latest was Later Stage VC in Mar 2026.
- Notable investors include Qiming Venture Partners, Huatai Zijin Investment, Shenzhen Yifeng Investment Management Enterprise, Hunan Chasing Fund, Leading Capital Company — 19 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 19 names
- ·Watchlist + deal alerts for TINGSN
- ·The full record, as it builds
Funding rounds
No funding rounds for TINGSN are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About TINGSN
Developer of Intracardiac echocardiography catheter imaging technology designed to treat cardiac arrhythmia. The company offers heart internal catheter positioning and software algorithms and is developing China's first computer surgical simulator for cardiac electrophysiology, based on a digital heart model and VR simulation operation as of 2021, thereby enabling doctors and students to practice for the actual scene of heart surgery
- Sector
- Healthcare
- HQ
- Nanjing, China
- Founded
- 2017
- Website
- tingsn.com/
- Ownership
- Privately Held (backing)
TINGSN doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in TINGSN shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on TINGSN in its N-PORT filings yet. We sweep new filings monthly.